β-Casomorphins 1–3 • Structure: • Chemical formula: C23H27N3O5 • Molecular weight: 425.48 g/mol
Bovine β-casomorphins 1–4 • Structure: • Chemical formula: C28H35N4O6 • Molecular weight: 522.61 g/mol
Bovine β-casomorphin 1–4, amide • Structure: -NH2 • Chemical formula: C28H35N5O5 • Molecular weight: 521.6 g/mol
Bovine β-casomorphin 5 • Structure: • Chemical formula: C30H37N5O7 • Molecular weight: 594.66 g/mol
Bovine β-casomorphin 7 • Structure: • Chemical formula: C41H55N7O9 • Molecular weight: 789.9 g/mol bBCM7 is produced in when digesting bovine A1 beta-casein outside of the body using pancreatic enzymes, and inside of some animal bodies. The A2 form, which follows Ile with a Pro instead of a His, is more resistant to the release of bBCM7, presumably because the proline residue blocks the action of a
carboxyl peptidase. bBCM7 has significant opioid effects when injected (and in more recent research, orally fed) into animals,
Human β-casomorphin 7 • Structure: Despite human beta-casein having a A2-like "P" after "I", human colostrum and early lactation-stage milk contains significant amounts of hBCM7. It is a much weaker opioid and the FVQ sequence renders it susceptible to further degradation.
Bovine β-casomorphin 8 • Structure: • Chemical formula (A2): C46H62N8O10 • Molecular weight (A2): 887.00 g/mol
X is H (histidine) in A1 and P (proline) in A2.
Bovine β-casomorphin 9 • Structure:
X is H (histidine) in A1 and P (proline) in A2. Produced from both A1 and A2. Opioid agonist, but apparently without the detrimental effect of bBCM7 in cell cultures and animal models, and in fact considered potentially beneficial. == Other bioactive casein-derived peptides ==